RecruitingNot ApplicableNCT07109557

The Effect of Baduanjin on Patients Undergoing Knee Replacement Surgery

The Effect of Baduanjin on Pain, Comfort, and Quality of Recovery in Patients Undergoing Knee Replacement Surgery


Sponsor

Niran Çoban

Enrollment

60 participants

Start Date

Jul 1, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

This randomized controlled trial aims to evaluate the effects of Baduanjin, a traditional Chinese mind-body exercise, on pain, comfort, and quality of recovery in patients undergoing total knee arthroplasty (TKA). The study will be conducted between July 2025 and July 2026 at Yalova Training and Research Hospital's Orthopedics Clinic. Sixty patients will be randomly assigned into two groups: an intervention group practicing Baduanjin and a control group receiving standard postoperative care. The intervention will begin on the first postoperative day and continue for three weeks. Outcome measures include the Visual Analog Scale (VAS) for pain, the General Comfort Questionnaire, and the Quality of Recovery-40 (QoR-40) questionnaire. These assessments will be conducted weekly for three weeks. The control group will follow routine postoperative care without Baduanjin. The primary objective is to determine whether Baduanjin can improve postoperative outcomes in terms of pain reduction, increased comfort, and better recovery quality.


Eligibility

Min Age: 18 YearsMax Age: 70 Years

Inclusion Criteria5

  • Having undergone Knee Replacement Surgery under general anesthesia
  • years old and over,
  • Are in stable condition after surgery,
  • Are conscious, and
  • Volunteer to participate in the study.

Exclusion Criteria3

  • Patients with contraindications to Baduanjin exercises,
  • Over 70 years old,
  • Using anxiolytic and sedative drugs,

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERBaduanjin

Baduanjin exercise


Locations(1)

Niran Çoban

Yalova, Turkey (Türkiye)

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07109557


Related Trials